One of the main advantages of the NMP22 test is its non-invasive nature. Unlike cystoscopy, which involves inserting a scope into the bladder, the NMP22 test only requires a urine sample. This makes it less uncomfortable for patients and reduces the risk of complications. Additionally, the test can be easily repeated to monitor disease progression or response to treatment.
